25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 0 0 2 24 2 12
BREAST 1150 11 574 90 1096 171 1041
ERLYTX 86 1 52 7 85 15 91
GI 170 3 157 10 122 29 177
GU 343 8 417 35 426 76 463
LEUK 162 4 209 15 183 37 225
LUNG 210 2 104 20 244 42 256
LYMPH 418 5 261 29 353 74 450
MELAN 48 0 0 0 0 0 0
MMYEL 118 3 157 10 122 21 128
MULT 50 2 104 5 61 12 73
OTHER 55 1 52 3 37 7 43
Total 2812 40 2087 226 2753 486 2959

25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES -- ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  3 2 104 3 37 3 18
CCD 183 3 157 24 292 43 262
ERLYTX 5 0 0 1 12 1 6
GU 5 1 52 1 12 1 6
LEUK 621 11 574 49 597 101 615
LUNG 379 8 417 33 402 58 353
OTHER 12 0 0 0 0 1 6
PEOLC 94 3 157 4 49 8 49
PREV 250 3 157 13 158 45 274
SXQOL 655 21 1096 64 779 112 682
Total 2207 52 2714 192 2338 373 2271

25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  5 2 104 5 61 5 30
BREAST 1150 11 574 90 1096 171 1041
CCD 183 3 157 24 292 43 262
ERLYTX 91 1 52 8 97 16 97
GI 170 3 157 10 122 29 177
GU 348 9 470 36 438 77 469
LEUK 783 15 783 64 779 138 840
LUNG 589 10 522 53 645 100 609
LYMPH 418 5 261 29 353 74 450
MELAN 48 0 0 0 0 0 0
MMYEL 118 3 157 10 122 21 128
MULT 50 2 104 5 61 12 73
OTHER 67 1 52 3 37 8 49
PEOLC 94 3 157 4 49 8 49
PREV 250 3 157 13 158 45 274
SXQOL 655 21 1096 64 779 112 682
Total 5019 92 4803 418 5089 859 5230

25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  2 0 0 2 24 2 12
BREAST 713 7 365 57 694 97 590
ERLYTX 56 1 52 6 73 11 67
GI 128 2 104 8 97 22 134
GU 262 7 365 25 304 56 341
LEUK 101 3 157 9 110 24 146
LUNG 129 1 52 11 134 25 152
LYMPH 274 3 157 18 219 48 292
MELAN 31 0 0 0 0 0 0
MMYEL 69 3 157 8 97 13 79
MULT 20 1 52 3 37 6 37
OTHER 54 0 0 2 24 6 37
Total 1839 28 1461 149 1813 310 1887

25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

NON-THERAPEUTIC STUDIES - ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  3 2 104 3 37 3 18
CCD 139 1 52 15 183 28 170
ERLYTX 5 0 0 1 12 1 6
GU 5 1 52 1 12 1 6
LEUK 265 4 209 19 231 43 262
LUNG 230 7 365 22 268 33 201
OTHER 12 0 0 0 0 1 6
PEOLC 73 3 157 4 49 8 49
PREV 250 3 157 13 158 45 274
SXQOL 480 14 730 46 560 77 469
Total 1462 35 1826 124 1510 240 1461

25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS BY SWOG INSTITUTIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
  8 3 157 8 97 8 49
BREAST 891 12 626 73 889 131 797
CCD 162 0 0 10 122 23 140
ERLYTX 61 1 52 7 85 12 73
GI 131 1 52 6 73 21 128
GU 298 8 417 29 353 59 359
LEUK 367 7 365 28 341 67 408
LUNG 383 10 522 38 463 62 377
LYMPH 274 3 157 18 219 48 292
MELAN 31 0 0 0 0 0 0
MMYEL 69 3 157 8 97 13 79
MULT 39 0 0 1 12 4 24
OTHER 160 0 0 2 24 7 43
PEOLC 73 0 0 4 49 7 43
PREV 250 3 157 13 158 45 274
SXQOL 480 14 730 46 560 77 469
Total 3677 65 3392 291 3542 584 3555

25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

THERAPEUTIC STUDIES COORDINATED BY SWOG

ACCRUAL REGISTRATIONS ONLY

COMMITTEE Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
BREAST 976 9 470 83 1011 157 956
ERLYTX 81 1 52 7 85 15 91
GI 100 1 52 4 49 17 103
GU 242 6 313 26 317 55 335
LEUK 130 3 157 13 158 32 195
LUNG 183 1 52 17 207 38 231
LYMPH 352 5 261 26 317 63 384
MMYEL 103 2 104 8 97 19 116
MULT 50 2 104 5 61 12 73
Total 2217 30 1565 189 2302 408 2484

25-JUL-2026 6:11

SWOG CURRENT AND PROJECTED ACCRUAL

ACCRUAL REGISTRATIONS ONLY

Inst. Accrual
Last
12 Months
Accrual
Last
7 Days
Yearly
Projection
(7 Days)
Accrual
Last
30 Days
Yearly
Projection
(30 Days)
Accrual
Last
60 Days
Yearly
Projection
(60 Days)
Member 1936 41 2139 150 1826 314 1911
AFFIL 141 2 104 7 85 21 128
CCOP/NCORP 1224 20 1044 116 1412 215 1309
Non-SWOG 1717 28 1461 144 1753 308 1875
Total 5018 91 4748 417 5076 858 5223

25-JUL-2026 6:11

STUDIES OPENED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
LEUK MM1OA-S04 MyeloMATCH: AML, ASTX727 + Ven (28D v 14D) 1 Y 22-JUL-26
ERLYTX S2505 Sarcoma, Stg II-IIIB, Surg + Short vs Std RT 1 Y 06-JUL-26

25-JUL-2026 6:11

STUDIES CLOSED THIS MONTH

ADMIN STUDYID STNAME REGTYPE Opened? Open Date
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 1 E 30-JUN-26
BREAST MA39 BREAST, Node-Pos, Reg RT vs No Reg RT 2 E 30-JUN-26
GI S1922 Small Bowel,Ram+Pac vs FOLFIRI, mets/unresect 1 N 15-JUL-26
ERLYTX S2012 Extrapulm NEC, Stg IV, Combo Chemo +/- Atezo 1 T 09-JUL-26

25-JUL-2026 6:11

STUDIES WITH 3 OR MORE REGISTRATIONS THIS WEEK

ADMIN STUDYID STNAME REGTYPE Registrations
LEUK MYELOMATCH MSRP for the NCI myeloMATCH Clinical Trials 1 11
BREAST S2206 Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva 1 11
SXQOL S2013 I-CHECKIT: ICI toxicity risk prediction study 1 10
LUNG LUNGMAP NSCLC, Adv, Master 1 8
BREAST S2212 Breast, TNBC, Neoadj Chemo + Pembro 1 8
LUNG LUNGMAP NSCLC, Adv, Master 2 5
SXQOL NRGCC015 E-Mindfulness After Breast Cancer 1 5
SXQOL S2205 ICE COMPRESS: Reduction of CIPN from Taxanes 1 5
LYMPH S2308 FL, LTB, Mosunetuzumab vs Rituximab 1 5
PEOLC S1501 Surv, Breast Stg IV, Card Tox w/ Carvedilol 2 3